Form 4 filings across 19 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$15.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 47 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 1 business day late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 150 most recent Form 4 transactions.
| 135,946 |
| Jun 26 |
| KYMR | Kymera Therapeutics, Inc. | $201.3M | $0 | +$201.3M | 8M | Jun 24 |
| MDGL | Madrigal Pharmaceuticals, INC. | $61.9M | $0 | +$61.9M | 1.9M | Jun 17 |
| ONC | BeOne Medicines Ltd. | $0 | $262K | -$262K | 161,550 | Jun 11 |
| PRLD | Prelude Therapeutics Inc | $0 | $0 | $0 | — | Jun 9 |
| DNLI | Denali Therapeutics Inc. | $0 | $0 | $0 | 3.4M | Jun 3 |
| KNSA | Kiniksa Pharmaceuticals… | $0 | $0 | $0 | 2.7M | May 29 |
| ACAD | Acadia Pharmaceuticals INC | $0 | $0 | $0 | 39.4M | May 29 |
| TCRX | TScan Therapeutics, Inc. | $0 | $0 | $0 | — | May 20 |
| DBVT | DBV Technologies S.A. | $0 | $0 | $0 | — | Jan 12 |
| BCYC | Bicycle Therapeutics PLC | $0 | $0 | $0 | 10M | Jan 2 |
| TRDA | Entrada Therapeutics, Inc. | $1.6M | $0 | +$1.6M | 4.7M | Nov 20, 2025 |
| KALA | KALA BIO, Inc. | $0 | $1.1M | -$1.1M | 425,006 | Oct 1, 2025 |
| IGMS | IGM Biosciences, Inc. | $0 | $0 | $0 | 0 | Aug 14, 2025 |
| IMCR | Immunocore Holdings plc | $0 | $0 | $0 | — | May 15, 2025 |
| Jul 14 | CELC | Celcuity Inc. | SSELL | 2.8M | $102.50 | $291M | -39.4% | Open the original filing on SEC.gov |
| Jul 14 | CELC | Celcuity Inc. | SSELL | 261,368 | $102.50 | $26.8M | -37.1% | Open the original filing on SEC.gov |
| Jun 30 | KOD | Kodiak Sciences Inc. | AGRANT◆ | 17,731 | — | — | — | Open the original filing on SEC.gov |
| Jun 30 | KOD | Kodiak Sciences Inc. | AGRANT◆ | 17,731 | — | — | — | Open the original filing on SEC.gov |
| Jun 30 | INCY | Incyte Corp | AGRANT | 400 | — | — | 0.0% | Open the original filing on SEC.gov |
| Jun 30 | INCY | Incyte Corp | AGRANT | 400 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Jun 26 | VTVT | vTv Therapeutics Inc. | AGRANT◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 26 | VTVT | vTv Therapeutics Inc. | AGRANT◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 6,068 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 6,068 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MDGL | Madrigal Pharmaceuticals,… | AGRANT◆ | 1,532 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MDGL | Madrigal Pharmaceuticals,… | AGRANT◆ | 1,532 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | MDGL | Madrigal Pharmaceuticals,… | AGRANT | 908 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Jun 17 | MDGL | Madrigal Pharmaceuticals,… | AGRANT | 908 | — | — | +0.4% | Open the original filing on SEC.gov |
| Jun 11 | ONC | BeOne Medicines Ltd. | AGRANT | 18,980 | — | — | +13.3% | Open the original filing on SEC.gov |
| Jun 11 | ONC | BeOne Medicines Ltd. | AGRANT | 18,980 | — | — | +13.3% | Open the original filing on SEC.gov |
| Jun 9 | PRLD | Prelude Therapeutics Inc | AGRANT◆ | 38,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | PRLD | Prelude Therapeutics Inc | AGRANT◆ | 38,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT◆ | 6,111 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT◆ | 6,111 | — | — | — | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT | 1,642 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Jun 8 | INCY | Incyte Corp | AGRANT | 1,642 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Jun 3 | DNLI | Denali Therapeutics Inc. | AGRANT◆ | 19,226 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | DNLI | Denali Therapeutics Inc. | AGRANT◆ | 19,226 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | DNLI | Denali Therapeutics Inc. | AGRANT | 6,408 | — | — | +0.2% | Open the original filing on SEC.gov |
| Jun 3 | DNLI | Denali Therapeutics Inc. | AGRANT | 6,408 | — | — | +1.9% | Open the original filing on SEC.gov |
| May 29 | ACAD | Acadia Pharmaceuticals INC | AGRANT◆ | 32,008 | — | — | — | Open the original filing on SEC.gov |
| May 29 | ACAD | Acadia Pharmaceuticals INC | AGRANT◆ | 32,008 | — | — | — | Open the original filing on SEC.gov |
| May 29 | ACAD | Acadia Pharmaceuticals INC | AGRANT | 18,622 | — | — | +<0.1% | Open the original filing on SEC.gov |
| May 29 | ACAD | Acadia Pharmaceuticals INC | AGRANT | 18,622 | — | — | +0.5% | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 36,474 | — | — | — | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 36,474 | — | — | — | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | AGRANT | 6,078 | — | — | +0.2% | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | AGRANT | 6,078 | — | — | +4.4% | Open the original filing on SEC.gov |
| May 22 | ONC | BeOne Medicines Ltd. | SSELL | 2,756 | $23.79 | $65.6K | -1.9% | Open the original filing on SEC.gov |
| May 22 | ONC | BeOne Medicines Ltd. | SSELL | 2,756 | $23.79 | $65.6K | -1.9% | Open the original filing on SEC.gov |
| May 22 | ONC | BeOne Medicines Ltd. | SSELL | 2,743 | $23.85 | $65.4K | -1.8% | Open the original filing on SEC.gov |
| May 22 | ONC | BeOne Medicines Ltd. | SSELL | 2,743 | $23.85 | $65.4K | -1.8% | Open the original filing on SEC.gov |
| May 20 | TCRX | TScan Therapeutics, Inc. | AGRANT◆ | 67,000 | — | — | — | Open the original filing on SEC.gov |
| May 20 | TCRX | TScan Therapeutics, Inc. | AGRANT◆ | 67,000 | — | — | — | Open the original filing on SEC.gov |
| May 8 | INCY | Incyte Corp | MEXER◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 8 | INCY | Incyte Corp | MEXER◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| May 8 | INCY | Incyte Corp | MEXER | 15,000 | $84.53 | $1.3M | +<0.1% | Open the original filing on SEC.gov |
| May 8 | INCY | Incyte Corp | MEXER | 15,000 | $84.53 | $1.3M | +0.5% | Open the original filing on SEC.gov |
| Apr 21 | PRLD | Prelude Therapeutics Inc | PDBUY◆ | 2.1M | $4.44 | $9.5M | — | Open the original filing on SEC.gov |
| Apr 21 | PRLD | Prelude Therapeutics Inc | PDBUY◆ | 114,601 | $4.44 | $508.8K | — | Open the original filing on SEC.gov |
| Apr 1 | REPL | Replimune Group, Inc. | AGRANT◆ | 44,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | REPL | Replimune Group, Inc. | AGRANT◆ | 44,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 31 | INCY | Incyte Corp | AGRANT | 421 | — | — | 0.0% | Open the original filing on SEC.gov |
| Mar 31 | INCY | Incyte Corp | AGRANT | 421 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Jan 12 | DBVT | DBV Technologies S.A. | MEXER◆ | 25M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | DBVT | DBV Technologies S.A. | MEXER◆ | 2.3M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | DBVT | DBV Technologies S.A. | MEXER◆ | 25M | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | DBVT | DBV Technologies S.A. | MEXER◆ | 2.3M | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | BCYC | Bicycle Therapeutics PLC | AGRANT◆ | 38,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | BCYC | Bicycle Therapeutics PLC | AGRANT◆ | 38,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | BCYC | Bicycle Therapeutics PLC | AGRANT | 19,000 | — | — | +0.2% | Open the original filing on SEC.gov |
| Jan 2 | BCYC | Bicycle Therapeutics PLC | AGRANT | 19,000 | — | — | +2.1% | Open the original filing on SEC.gov |
| Dec 31, 2025 | INCY | Incyte Corp | AGRANT | 328 | — | — | 0.0% | Open the original filing on SEC.gov |
| Dec 31, 2025 | INCY | Incyte Corp | AGRANT | 328 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Dec 18, 2025 | KOD | Kodiak Sciences Inc. | PBUY | 2.4M | $23.00 | $55M | +15.0% | Open the original filing on SEC.gov |
| Dec 18, 2025 | KOD | Kodiak Sciences Inc. | PBUY | 217,428 | $23.00 | $5M | +16.2% | Open the original filing on SEC.gov |
| Dec 11, 2025 | KYMR | Kymera Therapeutics, Inc. | PBUY | 1.8M | $86.00 | $158.1M | +30.1% | Open the original filing on SEC.gov |
| Dec 11, 2025 | KYMR | Kymera Therapeutics, Inc. | PBUY | 167,192 | $86.00 | $14.4M | +31.3% | Open the original filing on SEC.gov |
| Dec 11, 2025 | DNLI | Denali Therapeutics Inc. | PDBUY◆ | 2.1M | $17.49 | $36.6M | — | Open the original filing on SEC.gov |
| Dec 11, 2025 | DNLI | Denali Therapeutics Inc. | PDBUY◆ | 190,523 | $17.49 | $3.3M | — | Open the original filing on SEC.gov |
| Nov 20, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 13,082 | $9.07 | $118.7K | +0.3% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 1,186 | $9.07 | $10.8K | +0.3% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 13,386 | $9.07 | $121.4K | +0.3% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 1,213 | $9.07 | $11K | +0.3% | Open the original filing on SEC.gov |
| Nov 12, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 11,494 | $7.95 | $91.4K | +0.3% | Open the original filing on SEC.gov |
| Nov 12, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 1,040 | $7.95 | $8.3K | +0.3% | Open the original filing on SEC.gov |
| Nov 12, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 80,881 | $7.73 | $625.3K | +1.8% | Open the original filing on SEC.gov |
| Nov 12, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 7,321 | $7.73 | $56.6K | +2.0% | Open the original filing on SEC.gov |
| Nov 11, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 30,879 | $7.54 | $232.8K | +0.7% | Open the original filing on SEC.gov |
| Nov 11, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 2,795 | $7.54 | $21.1K | +0.8% | Open the original filing on SEC.gov |
| Nov 11, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 11,701 | $7.39 | $86.5K | +0.3% | Open the original filing on SEC.gov |
| Nov 11, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 1,059 | $7.39 | $7.8K | +0.3% | Open the original filing on SEC.gov |
| Nov 10, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 2,947 | $7.22 | $21.3K | +<0.1% | Open the original filing on SEC.gov |
| Nov 10, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 267 | $7.22 | $1.9K | +<0.1% | Open the original filing on SEC.gov |
| Nov 10, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 25,364 | $7.21 | $183K | +0.6% | Open the original filing on SEC.gov |
| Nov 10, 2025 | TRDA | Entrada Therapeutics, Inc. | PBUY | 2,296 | $7.21 | $16.6K | +0.6% | Open the original filing on SEC.gov |
| Oct 1, 2025 | KALA | KALA BIO, Inc. | SSELL | 462,967 | $1.38 | $640.7K | -52.1% | Open the original filing on SEC.gov |
| Oct 1, 2025 | KALA | KALA BIO, Inc. | SSELL | 50,640 | $1.38 | $70.1K | -52.1% | Open the original filing on SEC.gov |
| Sep 30, 2025 | KALA | KALA BIO, Inc. | SSELL | 195,425 | $1.60 | $311.9K | -18.0% | Open the original filing on SEC.gov |
| Sep 30, 2025 | KALA | KALA BIO, Inc. | SSELL | 21,376 | $1.60 | $34.1K | -18.0% | Open the original filing on SEC.gov |
| Sep 30, 2025 | INCY | Incyte Corp | AGRANT | 388 | — | — | 0.0% | Open the original filing on SEC.gov |
| Sep 30, 2025 | INCY | Incyte Corp | AGRANT | 388 | — | — | +<0.1% | Open the original filing on SEC.gov |
| Sep 8, 2025 | CELC | Celcuity Inc. | PBUY | 4,212 | $58.02 | $244.4K | +<0.1% | Open the original filing on SEC.gov |
| Sep 8, 2025 | CELC | Celcuity Inc. | PBUY | 388 | $58.02 | $22.5K | +<0.1% | Open the original filing on SEC.gov |
| Sep 8, 2025 | CELC | Celcuity Inc. | PBUY | 151,524 | $56.22 | $8.5M | +2.1% | Open the original filing on SEC.gov |
| Sep 8, 2025 | CELC | Celcuity Inc. | PBUY | 13,976 | $56.22 | $785.7K | +2.0% | Open the original filing on SEC.gov |
| Sep 3, 2025 | VTVT | vTv Therapeutics Inc. | AGRANT◆ | 2.4M | — | — | — | Open the original filing on SEC.gov |
| Sep 3, 2025 | VTVT | vTv Therapeutics Inc. | AGRANT◆ | 221,452 | — | — | — | Open the original filing on SEC.gov |
| Sep 3, 2025 | VTVT | vTv Therapeutics Inc. | AGRANT◆ | 2.4M | — | — | — | Open the original filing on SEC.gov |
| Sep 3, 2025 | VTVT | vTv Therapeutics Inc. | AGRANT◆ | 217,144 | — | — | — | Open the original filing on SEC.gov |
| Sep 3, 2025 | VTVT | vTv Therapeutics Inc. | AGRANT | 46,692 | — | — | +52.3% | Open the original filing on SEC.gov |
| Sep 3, 2025 | VTVT | vTv Therapeutics Inc. | AGRANT | 4,308 | — | — | +53.4% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 9,362 | $392.24 | $3.7M | +0.5% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 862 | $392.24 | $338.1K | +0.4% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 2,506 | $389.89 | $977.1K | +0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 231 | $389.89 | $90.1K | +0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 366 | $389.00 | $142.4K | +<0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 34 | $389.00 | $13.2K | +<0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 4,441 | $387.07 | $1.7M | +0.2% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 409 | $387.07 | $158.3K | +0.2% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 13,545 | $385.06 | $5.2M | +0.7% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 1,248 | $385.06 | $480.6K | +0.6% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 4,049 | $383.79 | $1.6M | +0.2% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 373 | $383.79 | $143.2K | +0.2% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 2,838 | $382.82 | $1.1M | +0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 262 | $382.82 | $100.3K | +0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 1,136 | $382.29 | $434.3K | +<0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 105 | $382.29 | $40.1K | +<0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 9,477 | $381.12 | $3.6M | +0.5% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 873 | $381.12 | $332.7K | +0.4% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 1,919 | $380.78 | $730.7K | +0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 176 | $380.78 | $67K | +<0.1% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 5,209 | $380.44 | $2M | +0.3% | Open the original filing on SEC.gov |
| Aug 20, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 480 | $380.44 | $182.6K | +0.2% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 7,325 | $374.43 | $2.7M | +0.4% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 675 | $374.43 | $252.7K | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 26,704 | $372.87 | $10M | +1.4% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 2,460 | $372.87 | $917.3K | +1.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 10,128 | $372.16 | $3.8M | +0.5% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 933 | $372.16 | $347.2K | +0.5% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 5,494 | $371.01 | $2M | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 506 | $371.01 | $187.7K | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 2,747 | $369.34 | $1M | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 253 | $369.34 | $93.4K | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 1,419 | $368.84 | $523.4K | +<0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 131 | $368.84 | $48.3K | +<0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 4,798 | $367.77 | $1.8M | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 442 | $367.77 | $162.6K | +0.2% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 2,289 | $366.30 | $838.5K | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 211 | $366.30 | $77.3K | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 2,772 | $363.75 | $1M | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 255 | $363.75 | $92.8K | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 5,587 | $362.39 | $2M | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 515 | $362.39 | $186.6K | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 5,443 | $361.37 | $2M | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 502 | $361.37 | $181.4K | +0.3% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 8,514 | $359.39 | $3.1M | +0.5% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 784 | $359.39 | $281.8K | +0.4% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 2,472 | $358.21 | $885.5K | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 228 | $358.21 | $81.7K | +0.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 8,328 | $357.02 | $3M | +0.5% | Open the original filing on SEC.gov |
| Aug 18, 2025 | MDGL | Madrigal Pharmaceuticals,… | PBUY | 767 | $357.02 | $273.8K | +0.4% | Open the original filing on SEC.gov |